chronic myeloid leukemia中文,chronic myeloid leukemia的意思,chronic myeloid leukemia翻译及用法

2025-10-08 07:50 浏览次数 7

chronic myeloid leukemia

[ˈkrɑnɪk ˈmaɪəˌlɔɪd luˈkimiə]

慢性骨髓白血病;慢性粒细胞白血病

chronic myeloid leukemia 英语释义

英语释义

    1. myelogenous leukemia that is marked by an abnormal increase in mature and immature granulocytes (as neutrophils, eosinophils, and myelocytes) especially in bone marrow and blood, that is characterized by fatigue, weakness, loss of appetite, spleen and liver enlargement, anemia, thrombocytopenia, and ultimately a dangerous increase in blast cells and especially myeloblasts and lymphoblasts, that occurs especially in adults, and that is associated with the presence of the Philadelphia chromosome —abbreviation CML — called also chronic granulocytic leukemia — compare acute myelogenous leukemia

chronic myeloid leukemia 片语

片语

Chronic myeloid myelogenous leukemia单核细胞白血病

chronic myeloid leukemia cml慢性粒细胞白血病

patients with chronic myeloid leukemia慢性髓性白血病

chronic myeloid leukemia cell line慢性粒细胞白血病细胞系

atypical chronic myeloid leukemia白血病

ph chronic myeloid leukemiaph慢性髓性白血病

CML Chronic Myeloid Leukemia慢性髓系白血病

cell chronic myeloid leukemia慢性髓性白血病

juvenile chronic myeloid leukemia幼年型慢性髓系白血病

chronic myeloid leukemia 例句

英汉例句

  • imatinib is currently the most popular therapy for chronic myeloid leukemia (cml).

    伊马替尼是目前治疗慢性髓细胞白血病的最普遍药物。

  • objective to study the vascular endothelium growth factor (vegf) antisense oligonucleotide (ason) cinobufotalin in enhancing apoptosis induced by human chronic myeloid leukemia k562 cell line.

    目的研究vegf反义核酸(ason)增强华蟾素对人慢性粒细胞白血病k562细胞株诱导凋亡效应。

  • plasma adiponectin levels are markedly elevated in imatinib-treated chronic myeloid leukemia (cml) patients: a mechanism for improved insulin sensitivity in type 2 diabetic cml patients?

    用伊马替尼治疗的慢性粒细胞白血病(cml)患者血浆脂联素浓度显着升高:这是改善2型糖尿病cml患者胰岛素敏感性的一种机制?

  • objective:observation of bone marrow smears of typical chronic myeloid leukemia to investigate the possibility of morphological classification of the disease.

    目的:观察典型慢性髓系白血病骨髓涂片,探讨用常规血细胞形态学方法分型的可能性。

  • objective to analyze the frequency and clinical significance of abl tyrosine kinase point mutations in chronic myeloid leukemia (cml) patients receiving imatinib treatment.

    目的探讨伊马替尼治疗慢性粒细胞白血病(cml)患者abl酪氨酸激酶区点突变的发生情况及临床意义。

  • chronic myeloid leukemia (cml) is a clonal hematologic malignancy that arise in the stem cell compartment .

    研究背景慢性髄细胞白血病(cml)是一种起源于多能造血干细胞的克隆性恶性血液病。

  • philadelphia chromosome formed may result in the generation of the fusion protein bcr abl, a constitutively activated tyrosine ki nas e which then causes chronic myeloid leukemia (cml).

    慢性粒细胞白血病(cml)患者体内有异常染色体形成并产生bcrabl融合蛋白,该融合蛋白能激活酪氨酸激酶,刺激细胞过度增生导致慢性粒细胞白血病的发生。

  • chronic myeloid leukemia (cml) is one of the most remarkable cancers.

    慢性髓样白血病(cml)是最不寻常的癌癥之一。

  • objective to study the changes of cytogenetics and molecular genetics in chronic myeloid leukemia blast crisis(cml-bc).

    目的研究慢性髓细胞白血病急变期(cml-bc)细胞遗传学及分子遗传学改变。

  • selecting optimal second-line tyrosine kinase inhibitor therapy for chronic myeloid leukemia patients after imatinib failure: does the bcr-abl mutation status really matter?

    选择最佳的二线酪氨酸激酶抑制剂治疗伊马替尼治疗失败的慢性粒细胞白细胞患者:bcr-abl突变状态是否真的重要?

  • recently, elevated il-18 levels were found in serum from some leukemia patients, especially those with acute lymphocytic leukemia (all) and chronic myeloid leukemia (cml).

    近来,研究发现急性淋巴细胞白血病(all)和慢性粒细胞白血病(cml)患者血清中il-18水平高于正常人。

相关热词